Clinical trial NCT04481061: Engaging Adolescents in Decisions About Return of Genomic Research Results
Official title: Engaging Adolescents in Decisions About Return of Genomic Research Results
Study type: INTERVENTIONAL
Overall status: ACTIVE_NOT_RECRUITING
Phase: NA
Conditions: Genetic Screening
Adolescent
Genetic Change
Shared Decision Making
Knowledge, Attitudes, Practice
Genetic Testing
Lead sponsor: Children's Hospital Medical Center, Cincinnati
Sponsor class: OTHER
Collaborators: name: University of Cincinnati
First posted: 2020-07-22
Enrollment: 787
Sex: ALL
Minimum age (years): 13
Maximum age (years): 99
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Intervention model description: Adolescents between 13-21 years of age will be given the option to learn categories of genomic results. Results will be returned based on their choices
Primary purpose: SCREENING

Brief summary: Recent recommendations to return children's results for adult-onset conditions to parents anytime whole exome or genome sequencing is performed, as well as growing expectations to return research results to participants on a large-scale basis, mean adolescents will increasingly be engaged in assenting (\<age 18) and consenting (\>age 18) to return of genomic research results. There is an urgent need to understand adolescents' informational preferences and to create ethically informed, scalable processes that empower adolescents from diverse backgrounds to participate in the decision-making process about learning genomic results. This research will provide important insights into adolescents' choices, as well as the ethical, legal and societal implications of engaging adolescents in making choices about learning genomic results in genomic research and community-based research settings.

Detailed description: The purpose of this study is to assess assenting and consenting adolescents' choices about learning genomic research results. The investigator will refine existing decision tools and processes to promote informed genomic decision-making through the use of focus groups with adolescents and parents recruited from an existing genomic research study and a diverse, medically-underserved community to assess whether and how recruitment pathways impact perceived value, risks, and benefits of participation in genomic research and return of personal genomic information. Once these materials have been refined, consenting adolescents between the ages of 18-21, assenting adolescents between the ages of 13-17, and their parents (optional for consenting adolescents) will be invited to make choices using an electronic decision tool for an actual return of results study using two different genome sequencing panels. A joint decision-making process involving adolescents, a parent (if applicable), and a study team member will facilitate confirmation of choices. A subset of adolescents will also be asked to reflect upon the genetic results they chose to learn, factors that impacted their choices, and decision-stability during in-depth interviews. Genomic research results will be returned that reflect the participants' choices. Surveys and interviews will be conducted following return of results to assess participants' understanding, perceived risks and benefits, psychosocial and behavioral impact, and whether decisional regret is associated with decisional stability. Throughout the study legal, ethical, and social issues pertaining to adolescents' preferences and responses to return of genomic research results will be explored, including normative assessments of empirical findings as well as the population-level utility and impact of involving adolescents in the decision-making process. Findings from this study will contribute to filling a critical gap in the literature regarding engaging adolescents' in the decision to learn genomic research results, and will help inform best practices with adolescent populations. This information is critical given recent recommendations by the American College of Medical Genetics to return children's results for adult onset conditions to parents' anytime whole exome or genome sequencing is performed. Findings from this study will also help inform a growing expectation to return research results on a large-scale basis, necessitating examination of ethical return of research results with a range of populations recruited from a variety of settings.

Eligibility criteria: Inclusion Criteria:

* Assenting adolescents (13-17 years)
* Consenting adolescents (18-21 years)
* Parent / legal guardian of assenting or consenting adolescent
* Ability to participate in remote study visits, if applicable

Exclusion Criteria:

* Those who do not meet inclusion criteria
* Those who do not communicate in English
* Individuals with developmental disabilities that interfere with their ability to make independent decisions

Primary outcomes:
measure: Change in Participant Choices Throughout the Study
timeFrame: Pre-intervention baseline choices made at enrollment; choices made during the intervention (about one hour after baseline); post-intervention choices (4 weeks after intervention); post return of results choices (an average of 1 year after intervention).
measure: Change in Participant's "Decisional Conflict Scale" Score Throughout the Study
timeFrame: Decisional Conflict will be measured at baseline, immediately after the intervention (about one hour after baseline), and four weeks after the intervention.
measure: Change in Participant Decisional Stability Throughout the Study
timeFrame: Measured at baseline, immediately after the intervention, (within an hour of baseline), and four weeks after the intervention.
measure: Measurement of Participant's Post Return of Results Decision Regret Score
timeFrame: Measurement taken within one week after returning results. This is an average of 1 year of the intervention.
Secondary outcomes:
Other outcomes:
Locations:
city: Rochester
country: United States
facility: Michelle McGowan
state: Minnesota
city: Cincinnati
country: United States
facility: Cincinnati Children's Hospital Medical Center
state: Ohio
Study officials:
References: